智慧注射器市场规模、份额和成长分析(按产品、应用、年龄层、最终用户和地区划分)—2026-2033年产业预测
市场调查报告书
商品编码
1899497

智慧注射器市场规模、份额和成长分析(按产品、应用、年龄层、最终用户和地区划分)—2026-2033年产业预测

Smart Syringes Market Size, Share, and Growth Analysis, By Product (Auto-disable syringes, Active safety syringes), By Application (Drug delivery, Vaccination), By Age Group, By End User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 242 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到 2024 年,全球智慧注射器市场规模将达到 98.2 亿美元,到 2025 年将达到 105.9 亿美元,到 2033 年将达到 193.1 亿美元,预测期(2026-2033 年)的复合年增长率为 7.8%。

由于人们对安全注射技术的认识不断提高,以及因使用不安全注射器而导致的血液传播疾病日益增多,全球智慧注射器市场正经历显着增长。智慧注射器旨在预防针刺伤和感染疾病传播,在疫苗接种、药物给药和血液采集等各种医疗应用中变得至关重要。此外,慢性病的增加和人口老化也促使人们需要更安全、更有效的医疗干预措施,这进一步推动了市场需求。儘管智慧注射器具有许多优势,但与传统注射器相比,其较高的成本对其广泛应用构成了挑战,尤其是在中低收入国家,这可能会限制市场扩张。然而,日益严格的安全标准推动了市场成长。

全球智慧注射器市场驱动因素

随着目标疾病数量的增加,全球各地疫苗接种活动正在不断扩大。此外,降低医院感染发生率的迫切需求显着推动了对智慧注射器的需求。同时,老年人口的成长也促进了对这类先进医疗设备的需求。这些因素共同表明,智慧注射器在现代医疗保健中的重要性日益凸显,也反映了注射方式朝向更有效率、更安全方向发展的趋势。这一趋势凸显了创新解决方案在应对全球公共卫生挑战方面的重要作用。

全球智慧注射器市场限制因素

全球智慧注射器市场面临严峻挑战,因为与传统注射器相比,这些先进医疗设备的成本较高。虽然某些型号的价格分布,但许多产品的价格可能要高得多,具体取决于其安全功能中采用的技术水准。这种价格差异使得智慧注射器难以负担,尤其是在中低收入国家。此外,开发和维护安全注射器所需的大量资金投入,以及技术进步带来的价格波动,进一步阻碍了市场成长,限制了智慧注射器的普及和可及性。

全球智慧注射器市场趋势

全球智慧注射器市场呈现显着上升趋势,尤其受到药物传递领域的推动,这得益于疫苗接种、药物管理和血液采集等应用领域的不断扩展。医院和医疗管理机构对自动丢弃(AD)注射器的需求日益增长,凸显了对安全和预防的重视,特别是最大限度地减少针刺伤和确保正确用药。此外,被动安全注射器市场也正在蓬勃发展,反映出整个产业正朝着创新、易用且能提升病患安全性的设备方向转变。这一发展势头使智慧注射器成为全球现代医疗保健系统中不可或缺的一部分。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数(2025)
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析

全球智慧注射器市场规模(按产品和复合年增长率划分)(2026-2033 年)

  • 自毁式註射器
  • 主动安全注射器
  • 被动安全注射器

全球智慧注射器市场规模(按应用领域及复合年增长率划分)(2026-2033 年)

  • 药物管理
  • 疫苗接种
  • 血液检体采集

全球智慧注射器市场规模(按年龄组别划分)及复合年增长率(2026-2033 年)

  • 儿童
  • 成人

全球智慧注射器市场规模(依最终用户划分)及复合年增长率(2026-2033 年)

  • 医院及健康维护组织
  • 糖尿病患者
  • 家庭医学
  • 精神病学
  • 其他的

全球智慧注射器市场规模及复合年增长率(2026-2033)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位(2025 年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析(2025 年)
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Becton, Dickinson and Company(BD)(USA)
  • B. Braun Melsungen AG(Germany)
  • Terumo Corporation(Japan)
  • Medtronic plc(Ireland)
  • Smiths Medical(UK)
  • Cardinal Health, Inc.(USA)
  • Gerresheimer AG(Germany)
  • Nipro Corporation(Japan)
  • Merit Medical Systems, Inc.(USA)
  • Retractable Technologies, Inc.(USA)
  • Revolution Medical Corporation(USA)
  • Codan Ltd(Denmark)
  • Baxter International Inc.(USA)
  • ICU Medical, Inc.(USA)
  • Hindustan Syringes & Medical Devices Limited(India)
  • Schott AG(Germany)
  • West Pharmaceutical Services, Inc.(USA)
  • MC Johnson Company(USA)
  • Changzhou Mingle Medical Equipment Co., Ltd.(China)
  • Hi-Tech Syringes(India)

结论与建议

简介目录
Product Code: SQMIG35A2214

Global Smart Syringes Market size was valued at USD 9.82 Billion in 2024 and is poised to grow from USD 10.59 Billion in 2025 to USD 19.31 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The global smart syringes market is experiencing significant growth due to heightened awareness of safe injection practices and the increasing prevalence of blood-borne diseases stemming from unsafe syringe usage. Smart syringes, designed to prevent needle stick injuries and the transmission of infectious diseases, are becoming essential in various medical applications, including vaccinations, drug delivery, and blood sampling. The demand is further fueled by the rise in chronic diseases and an aging population, which necessitate safer and more effective medical interventions. Despite their benefits, the higher cost of smart syringes compared to traditional models poses challenges for broader adoption, particularly in low- and middle-income countries, potentially restricting market expansion. Nonetheless, the push for enhanced safety standards supports market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Syringes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Syringes Market Segments Analysis

Global Smart Syringes Market is segmented by Product, Application, Age Group, End User and region. Based on Product, the market is segmented into Auto-disable syringes, Active safety syringes and Passive safety syringes. Based on Application, the market is segmented into Drug delivery, Vaccination and Blood specimen collection. Based on Age Group, the market is segmented into Pediatrics and Adults. Based on End User, the market is segmented into Hospitals and HMOs, Diabetic Patients, Family Practices, Psychiatrics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Smart Syringes Market

The rise in targeted diseases has led to an escalation in vaccination initiatives across numerous global regions. Additionally, the pressing need to mitigate the incidence of hospital-acquired infections is significantly boosting the demand for smart syringes. Furthermore, the increasing population of elderly individuals is contributing to the heightened requirement for such advanced medical devices. These factors collectively underline the growing relevance and necessity of smart syringes in modern healthcare, reflecting a shift towards more efficient and safer injection practices. This trend highlights the critical role of innovative solutions in addressing public health challenges worldwide.

Restraints in the Global Smart Syringes Market

The global smart syringes market faces significant challenges due to the higher costs associated with these advanced medical devices compared to traditional syringes. While some models may be on par in price with single-use syringes, many can be significantly more expensive, depending on the level of technology integrated into their safety features. This price discrepancy presents affordability issues, particularly in low- and middle-income nations. Additionally, the substantial capital investment necessary for the development and maintenance of safety syringes, along with price volatility linked to technological advancements, further hinders the growth of the market, limiting widespread adoption and accessibility.

Market Trends of the Global Smart Syringes Market

The Global Smart Syringes market is experiencing a significant upward trend, fueled by increasing applications in vaccination, drug administration, and blood sampling, with drug administration leading the way. The rising demand for Auto-disabled (AD) syringes from hospitals and healthcare management organizations underscores a growing emphasis on safety and prevention, particularly to minimize needle-stick injuries and ensure proper medication delivery. Additionally, the passive safety syringe segment is gaining traction, reflecting a broader industry shift toward innovative, user-friendly devices that enhance patient safety. This momentum positions smart syringes as an integral component of modern healthcare delivery systems worldwide.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Smart Syringes Market Size by Product & CAGR (2026-2033)

  • Market Overview
  • Auto-disable syringes
  • Active safety syringes
  • Passive safety syringes

Global Smart Syringes Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Drug delivery
  • Vaccination
  • Blood specimen collection

Global Smart Syringes Market Size by Age Group & CAGR (2026-2033)

  • Market Overview
  • Pediatrics
  • Adults

Global Smart Syringes Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals and HMOs
  • Diabetic Patients
  • Family Practices
  • Psychiatrics
  • Others

Global Smart Syringes Market Size & CAGR (2026-2033)

  • North America (Product, Application, Age Group, End User)
    • US
    • Canada
  • Europe (Product, Application, Age Group, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Application, Age Group, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Application, Age Group, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Application, Age Group, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Becton, Dickinson and Company (BD) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smiths Medical (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardinal Health, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Gerresheimer AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nipro Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Retractable Technologies, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Revolution Medical Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Codan Ltd (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICU Medical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hindustan Syringes & Medical Devices Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Schott AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • West Pharmaceutical Services, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • M.C. Johnson Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Changzhou Mingle Medical Equipment Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hi-Tech Syringes (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations